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Edited by Judit OvadiAbstract Acylaminoacyl peptidase is a member of the prolyl
oligopeptidase family. Amino acid sequence alignment suggests
that the stabilization of the tetrahedral intermediate should be
mediated by His507 rather than by a tyrosine residue found in
the other family members of this serine peptidase group. The pH
dependence of kcat/Km did not reveal any eﬀect of His507.
Substitution of an alanine for His507 gave the same bell-shaped
pH rate proﬁle with the same pKa values (7.0 and 8.7). However,
the value of the rate constant was 85 times lower with the
modiﬁed enzyme, which indicated that His507 is an important
residue that is probably involved in the formation of the 3-
dimensional structure.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Acylaminoacyl peptidase (acyl-amino-acid-releasing en-
zyme, acylpeptide hydrolase) belongs to the recently identiﬁed
prolyl oligopeptidase family of serine peptidases cf. [1,2],
which is diﬀerent from the classic serine peptidases, like trypsin
and subtilisin. Prolyl oligopeptidase is implicated in the me-
tabolism of neuropeptides and is involved in amnesia and
depression cf. [3]. Crystal structure determination has revealed
that it contains a peptidase and an unusual b-propeller domain
that accounts for the oligopeptidase activity by excluding large
peptides and proteins from the active site [4]. Sequence align-
ment of important members of the family, like prolyl oligo-
peptidase, acylaminoacyl peptidase and dipeptidyl peptidase
IV [1], indicated that the relationship is the closest between
prolyl oligopeptidase and acylaminoacyl peptidase. The ho-
mology in the family is always higher for the peptidase than for
the propeller domain. Indeed, prolyl oligopeptidase has a
seven-bladed propeller, whereas that of dipeptidyl peptidase is
eight-bladed, as shown by the most recently determined crystal
structure of dipeptidyl peptidase IV [5–9]. Sequence alignment* Corresponding author. Fax: +36-1-466-5465.
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is seven-bladed.
In contrast to prolyl oligopeptidase and oligopeptidase B,
which are monomers both in solution and in crystal structure
[4], and dipeptidyl peptidase, which is a dimer [5–9], mam-
malian acylaminoacyl peptidases are composed of four iden-
tical subunits. The enzyme catalyzes the removal of an
N-acylated amino acid from blocked peptides cf. [10]. The
blocked peptides containing two or three amino acids are hy-
drolyzed faster than the longer peptides, but N-acylated pro-
teins are not substrates for the enzyme [10]. The members of
the catalytic triad were identiﬁed by sequence homology
studies [1,11] and chemical modiﬁcations by inactivating the
enzyme by diisopropyl ﬂuorophosphate at Ser587 and by
chloromethyl compounds at His707. The third member of the
triad is Asp675, which was conﬁrmed by site-speciﬁc muta-
genesis cf. [10].
A major catalytic diﬀerence from the trypsin- and subtilisin-
type enzymes concerns the stabilization of the negatively
charged tetrahedral intermediate. This is achieved by the
oxyanion binding site, which provides two hydrogen bonds to
the oxyanion. In the trypsin-type enzymes, the hydrogen bonds
are contributed by two main chain NH groups, whereas in the
subtilisin and its homologs one of the hydrogen bonds origi-
nates from the side chain amide of an asparagine residue
cf. [12]. In prolyl oligopeptidase, one hydrogen bond is formed
between the oxyanion and the main chain NH group of
Asn555, adjacent to the catalytic Ser554. The other bond co-
mes from the OH group of Tyr473 [4]. Sequence alignment
suggests that a tyrosine residue in the same position is en-
countered in all oligopeptidases, except in acylaminoacyl
peptidase, where a histidine (His507) occupies the place of the
tyrosine (Fig. 1). The His507 is conserved throughout diﬀerent
organisms, from bacteria to mammals. In this paper, we have
investigated whether His507 is involved in the catalysis.2. Materials and methods
2.1. Preparation of porcine liver acylaminoacyl peptidase
All preparations were carried out at 4 C, unless otherwise stated. 2.5
kg porcine liver was homogenized in 3 L of buﬀer 1 (50 mM phosphate
buﬀer, pH 7.2, containing 1 mM ethylenediaminetetraacetic acid
(EDTA), 5 mM, 2-mercaptoethanol, and 5 mM Na2SO3). The mixture
was heated to 64 C for 7 min as described earlier [13], then cooled on
ice and centrifuged. The supernatant was further puriﬁed on a DE52
column (56 230 mm, Whatman International Ltd. Maidstone,blished by Elsevier B.V. All rights reserved.
Fig. 1. Multiple sequence alignment of the peptidase domains of oligopeptidases. The amino acid sequences are AAP, porcine liver acylaminoacyl
peptidase [17]; POP, pig brain prolyl oligopeptidase [18]; DIP IV, rat liver dipeptidyl peptidase IV [19]; and OpB, E. coli oligopeptidase B [20]. The
oxyanion binding site Tyr and the Ser, His, and Asp of the catalytic triad are highlighted.
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enzyme was eluted with a linear salt gradient (0–1 M NaCl, 1000 ml of
each component of buﬀer 2). The active fractions were combined and
the enzyme was precipitated by the addition of (NH4)2SO4 to 50%
saturation. After incubation for 2 h, it was centrifuged and the pre-
cipitate was dissolved in buﬀer 1. The solution was passed through a
Cibacrone Blue column (28 170 mm, Sigma–Aldrich). The active
fractions were collected and after concentration in Centricon mem-
brane, MWCO 30 kDa (Millipore), the ﬁnal puriﬁcation was achieved
on a MonoQ HR10 column (Pharmacia LKB). Acylaminoacyl pepti-
dase was eluted with a linear gradient from 0.25 to 0.45 M NaCl in 20
mM phosphate buﬀer, pH 7.2, containing 1 mM EDTA, using the
FPLC system. The yield was 10 mg.2.2. Cloning of wild type N-terminally His-tagged acylaminoacyl
peptidase gene
The porcine acylaminoacyl peptidase gene from a pET23a vector
(obtained from S. Tsunasawa [14]) was opened with BamHI restriction
endonuclease and was ampliﬁed with the polymerase chain reaction
(PCR) method, using the primers 30-gatgcgtgtgtgaacccgtcg-
attcctaggtga-50 (50-primer) and 50-atcagtacatatggaacgtcaggtgctgctg-30
(30-primer), containing BamHI and NdeI recognition sites (underlined),
respectively. The acylaminoacyl peptidase gene was digested with NdeI
and BamHI endonucleases, puriﬁed with 1% agarose gel-electropho-
resis and ligated into the pET15b plasmid, digested with the same
restriction enzymes. The pET15b plasmid adds a His-tag to the
N-terminus of the protein, which can be cleaved by thrombin. Finally,
the plasmid was ampliﬁed in Escherichia coli DH5a strain.
2.3. Constructing the H507A mutant acylaminoacyl peptidase gene
bearing a His-tag at the N-terminus
The pET23a plasmid opened with BamHI was employed as a
template for introducing the mutation with PCR. In the ﬁrst step, the
gene was ampliﬁed between nucleotides 1 and 1539, using the 50-
primer (preceding paragraph) and antisense primer coding for themutation (50-gtccccctgcaggcatgacca-30). An extra PstI recognition site
(underlined) was also introduced with the primer. In the second step,
the gene was ampliﬁed between nucleotides 1501 and 2199, using the
30 primer (preceding paragraph) and the sense primer coding for
mutation (50-tggtcatgcctgcagggggac-30). The two gene fragments were
fused and ampliﬁed with another PCR in the presence of the 30 and 50
primers. The mutant gene was digested with NdeI and BamHI en-
zymes and ligated into pET15b vector opened with the same restric-
tion enzymes.
2.4. Preparation of recombinant acylaminoacyl peptidase proteins
The same preparation method was used for the wild type enzyme
and the H507A variant. The pET15b plasmid harboring the acyla-
minoacyl peptidase gene was transformed into BL21(DE3)-pLysS
E. coli cells. 5–6 single cell colonies grown up on agar plate were
added to each of 20 600 ml of LB medium containing 100 lg/ml
ampicillin and 25 lg/ml chloramphenicol. The induction was per-
formed with 13 lM isopropyl b-D-thiogalactoside at about OD 0.6.
The cells were incubated at 32 C for 70 h. The next preparation
steps were carried out at 4 C. The cell paste (75 g wet weight,
obtained from 20 600 ml) was sonicated in 260 ml of 50 mM
phosphate buﬀer, pH 8.0, and 2 mM Na2SO3. The supernatant of
the sonicate was ﬁltered and applied to a Ni–NTA column (Qiagen
Gmbh, Hilden, Germany). The acylaminoacyl peptidase was step-
wise eluted with 20, 50, 100 and 200 mM imidazole. The active
fractions (50 and 100 mM imidazole) were concentrated by ultra-
ﬁltration to 2 ml and washed to remove imidazole. To eliminate the
His-tag, 10 U of thrombin/mg acylaminoacyl peptidase was added.
The reaction mixture was incubated overnight at room temperature
and puriﬁed on a MonoQ HR10, and then a Superose 12 column in
buﬀer 2. The protein concentration of the pure enzyme was calcu-
lated from the absorbance at 280 nm by using Mr value of 324 957
for the tetramer and A280 (0.1%) of 1.48. The overall yield was 1 mg
protein from the wild type and 120 lg from H507A enzyme variant.
The latter exhibited much greater tendency for denaturation than
did the former.
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The reaction of acylaminoacyl peptidase with acetyl-Ala-4-nitro-
anilide (Bachem Ltd., Bubendorf, Switzerland) was measured spec-
trophotometrically, using a Cary 100 spectrophotometer equipped
with a Peltier cell holder accessory and a temperature controller. The
liberation of 4-nitrophenol was monitored at 410 nm. The ﬁrst-order
rate constants were measured at substrate concentrations lower than
0.1 Km and were calculated by nonlinear regression analysis, using the
GraFit software [15]. The speciﬁcity rate constants, kcat/Km, were ob-
tained by dividing the ﬁrst-order rate constant by the total enzyme
concentration in the reaction mixture. Theoretical curves for bell-
shaped pH rate proﬁles were calculated by nonlinear regression anal-
ysis [15]. The buﬀer used in a wide pH range contained 25 mM
2-(morpholino)ethanesulfonic acid, 25 mM acetic acid, 75 mM Tris,
25 mM glycine, 1 mM EDTA and 0.3 M NaCl. The buﬀers were ad-
justed to the appropriate pH values with 1 M HCl or 1 M NaOH. The
substrate was dissolved in dimethylsulfoxide. The concentration of
the organic solvent in the reaction mixture was less than 0.006%. The
substrate concentration was 1.38 lM, and the enzyme concentrations
were 3 and 60 nM for the wild type and the H507A variant, respec-
tively. The analyses were carried out at 25 C.3. Results and discussion
The catalytic triad, which consists of serine, histidine and
aspartate residues, is an essential part of the catalytic ma-
chinery of serine peptidases. The catalytic histidine functions
as a general base catalyst that assists the proton transfer from
the serine OH to the leaving group of the substrate through the
formation of a tetrahedral intermediate formed on the reaction
path. This process generates an acyl enzyme, which is subse-
quently hydrolyzed by the reverse mechanism of acylation
cf. [12].
The pKa of histidine is about 7, and thus it should be seen in
the pH-rate proﬁle of serine protease reactions, because on
protonation the histidine becomes catalytically inactive.
Therefore, we have determined the pH dependence of the
speciﬁcity rate constant for acylaminoacyl peptidase (kcat/Km),
which is aﬀected by the ionization state of the imidazole group.
Fig. 2 shows that the kcat/Km follows a bell-shaped pH de-
pendence having two pKa values, one refers to the catalytic
histidine, His707 (pK1¼ 7.0), the other probably to confor-
mational changes (pK2¼ 8.7). A similar bell-shaped curve was
observed with chymotrypsin [12], whereas with subtilisin, inFig. 2. The pH dependence of kcat/Km for the acylaminoacyl peptidase
reactions. Wild type enzyme (s, solid line, left ordinate), parame-
ters for the curve: pK1¼ 7.01 0.03, pK2¼ 8.65 0.03, and
kcat/Km¼ 2.28 0.05 lM1 s1. H507A variant (n, dashed line, right
ordinate), parameters for the curve: pK1¼ 6.94 0.07, pK2¼ 8.69
0.08, and kcat/Km¼ 0.0269 0.002 lM1 s1.the absence of conformational changes, a simple sigmoid curve
is obtained with a single pKa of about 7.2 [12].
While the bell-shaped-curve in Fig. 2 implies the participa-
tion of the catalytic histidine base (His707), it does not support
the contribution of a second histidine, i.e., His507, from the
oxyanion binding site. The imidazole group contains two ni-
trogen atoms, one nitrogen is always protonated in the pH
range studied and the other may be protonated or unproto-
nated, depending on the pH. Of course, only the protonated
nitrogen is able to oﬀer a hydrogen bond to the oxyanion.
However, such a contribution of His507, i.e., an increase in
rate, is not seen in Fig. 2 below pH 7, where the protonation of
His507 would compensate for the decrease in rate when His707
becomes protonated.
Only a very low pKa for His507 (<5) would be consistent
with the bell-shaped curve of Fig. 2, when the neutral imid-
azole side chain serves as the oxianion binding site. Such a
decrease in the pKa of His507 can be elicited by nearby positive
charges of Lys or Arg residues. However, the electrostatic ef-
fects of the charges should be shielded by an increase in ionic
strength of the medium. Moreover, addition of 0.3 M NaCl
did not inﬂuence the pH-rate proﬁle shown in Fig. 2. A further
explanation of the electrophilic catalysis by His507 may be
that a water molecule that binds to His507 serves as the oxi-
anion binding site. The contribution of the bound water
molecule, however, would be aﬀected by the dissociation of
His507, and this would perturb the bell-shaped curve. In ad-
dition, such a mechanism would be entropically unfavorable.
It may be assumed that in a special enzymatic environment
the pKa of His507 may be so high that the imidazole ring is
protonated up to pH 8.7 and this would account for the de-
crease of kcat/Km in the alkaline pH region. However, such an
environment that could raise the pKa by 1.7 units is unlikely. If
the NH group of the imidazole ring, which holds the proton
over the entire pH range studied, provided the hydrogen bond,
then the eﬀect of ionization of the other nitrogen would be seen
around pH 7, in contrast to the present ﬁnding. Consequently,
the participation of His507 in the stabilization of the oxyanion
is not probable.
The above data do not rule out that His507 might exhibit an
unusually high pKa, and the protonated imidazole serves as a
catalyst up to pH 8.7, where the protonated imidazole does not
even lose the proton. A convincing evidence that excludes
His507 as a catalytic entity can be obtained by using the
H507A variant of acylaminoacyl peptidase. To this end, we
have expressed the porcine liver acylaminoacyl peptidase in E.
coli. The yield was rather low, but enough for the comparison
of the recombinant enzyme with that isolated from porcine
liver. The kinetic parameters were identical for the natural and
the recombinant enzymes within experimental error. The
acylaminoacyl peptidase was then modiﬁed by substituting an
alanine for the His507. The pH rate proﬁles were similar
for the native enzyme and the H507A variant (Fig. 2), sug-
gesting that the ionization of His507 does not signiﬁcantly
inﬂuence the pKa values and does not participate in the sta-
bilization of the oxyanion of the tetrahedral intermediate.
Although the pKa values extracted from the pH-rate proﬁles
are not aﬀected by the removal of His507, the kcat/Km value for
the H507A variant was 85 times less than that for the wild type
enzyme (Fig. 2). Thus, His507 is an important residue, even
though it is not a catalytic group. It is probable that His507
has structural importance; its side chain may interact with
20 A.L. Kiss et al. / FEBS Letters 571 (2004) 17–20other groups, ensuring the proper enzyme conformation for
catalysis. His507 must be close to the active site so that a small
conformational change may elicit substantial catalytic eﬀects.
Because we do not see the eﬀect of either a histidine or a ty-
rosine residue, the latter could be seen above pH 9, it is pos-
sible that two main chain NH groups are involved in the
stabilization as found in the chymotrypsin-type enzymes. The
role of His507 in the stabilization of the protein structure is
also supported by the lower yield obtained with the H507A
variant.
The conformational change caused by the modiﬁcation of
His507 could exert an eﬀect on the oligomerization of the
protomers or dimers. However, both the wild type and the
modiﬁed enzyme eluted at the same position during chroma-
tography on a Superose 12 column, indicating that the tetra-
mer structure was preserved with the H507A variant.
It can be concluded that His507 does not contribute to the
stabilization of the tetrahedral intermediate by providing a
hydrogen bond to the oxyanion. This is not surprising because
the imidazole group is unprotonated in the catalytically eﬀec-
tive pH range. Therefore, we assume that the main chain
folding of the segment holding the His507 residue is diﬀerent
from the corresponding segment of prolyl oligopeptidase and
dipeptidyl peptidase IV. Protein structure prediction based on
amino acid sequence alignment is not always straightforward.
For example, a seven-bladed propeller was assigned for di-
peptidyl peptidase IV on the basis of low homology with prolyl
oligopeptidase [16], whereas later crystal structure determina-
tion established an eight-bladed propeller [5–9].Acknowledgements: The authors thank Dr. S. Tsunasawa for providing
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